The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Acrux (ACR) receives approval from the US FDA to review a generic version of its nitroglycerin ointment at 0.4 per cent concentration
  • The company applied for an abbreviated new drug application for the generic version, if approved by the FDA will allow ACR to market the generic ointment to patients
  • Nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissures
  • The total addressable market for the current product is almost US$19.9 million
  • Shares rose 9.52 per cent to 4.6 cents at 12:59 pm AEST

Acrux (ACR) has received approval from the United States Food and Drug Administration (FDA) to review a generic version of its nitroglycerin ointment at 0.4 per cent concentration.

The company applied for an abbreviated new drug application for the generic version which, if approved by the FDA will allow ACR to market the generic ointment to patients.

Nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissures.

The original drug is currently listed as Rectiv Ointment, 0.4 per cent, and marketed by AbbVie in the US.

The total addressable market for the current product is almost US$19.9 million (A$29.7 million) with no FDA-approved generic version of the ointment available on the US market.

Acrux is currently advancing a variety of other topical products which are in varying stages of development, totalling 16 products.

Acrux shares rose 9.52 per cent to 4.6 cents at 12:59 pm AEST.

ACR by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Consumer Discretionary rises ahead of interest rates decision | June 14, 2024

The ASX200 is down a third of a per cent to close the week. All sectors…
The Market Online Video

ASX Market Update: ASX slips 0.3%, Discretionary is the only sector to rise | 14 June, 2024

The ASX200 is trading down around 0.3%. The discretionary sector has made gains of 0.3%, all…

Week 24 Wrap: US contagion sentiment not so contagious; iron ore remains pressured

It was, overall, a lacklustre week for the ASX. We only saw one green day on…
The Market Online Video

Geology is King: Sun Silver says Maverick Springs will outshine high-grade Australian mines

Sun Silver Ltd (ASX:SS1) is seeking gold, silver and pathfinder elements at their Maverick Springs project…